ENTG:NASDAQEntegris, Inc. Analysis
Data as of 2026-09-14 - not real-time
$140.37
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Entegris, Inc. trades at $140.37, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Over a rolling month the price has gained 19.9%. Relative strength is 50.0 — neutral — and the MACD signal is bullish. Watch $125.78 as support and $166.20 as the nearer resistance level.
Multiples put this in fair territory: 70.5 times earnings against the sector's 33.2. Sell-side targets cluster 23.5% above the current quote. Revenue is growing at 11.5% on a 9.2% profit margin. The 0.28% dividend yield looks covered by current payout levels.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 73.1%, a beta of 3.39 and a maximum drawdown of 41.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Timeframes disagree: the short-term read is buy while the long-term read is hold, conviction 2 out of 10.
Multiples put this in fair territory: 70.5 times earnings against the sector's 33.2. Sell-side targets cluster 23.5% above the current quote. Revenue is growing at 11.5% on a 9.2% profit margin. The 0.28% dividend yield looks covered by current payout levels.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 73.1%, a beta of 3.39 and a maximum drawdown of 41.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Timeframes disagree: the short-term read is buy while the long-term read is hold, conviction 2 out of 10.
Top Market Events
Artisan Partners, an investment management company, released its second-quarter 2026 investor letter for the “Artisan...As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in...Looking back on semiconductor manufacturing stocks’ Q2 earnings, we examine this quarter’s best and worst...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 127.53
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 70.5 versus sector average of 33.2
- Trading above the 200-day average of 127.53
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 70.5 versus sector average of 33.2
- Analyst targets imply +23.5% versus the current price
- Revenue growth of +11.5%
Key Metrics & Analysis
Financial Health
Revenue Growth11.50%
Profit Margin9.19%
P/E Ratio70.5
ROE7.67%
ROA4.13%
Debt/Equity85.66
P/B Ratio5.2
Op. Cash Flow$780.7M
Free Cash Flow$477.8M
Industry P/E33.2
Technical Analysis
TrendBullish
RSI50.0
Support$125.78
Resistance$166.20
MA 20$141.75
MA 50$139.48
MA 200$127.53
MACDBullish
VolumeStable
Fear & Greed Index93.14
Valuation
Fair Value$41.46
Target Price$173.36
Upside/Downside23.50%
GradeFair
TypeGrowth
Dividend Yield0.28%
Risk Assessment
Beta3.39
Volatility73.10%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.